Article Versions Notes

Zhou Y, Yuan Z, Wang M, Zhang Z, Tan C, Yu J, Bi Y, Liao X, Zhou X, Ali Sheikh MS, et al. Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice. Journal of Cardiovascular Development and Disease. 2023; 10(9):386. https://doi.org/10.3390/jcdd10090386

Zhou, Yangzhao, Zhaoshun Yuan, Min Wang, Zhiyuan Zhang, Changming Tan, Jiaolian Yu, Yanfeng Bi, Xiaobo Liao, Xinmin Zhou, Md Sayed Ali Sheikh, and et al. 2023. "Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice" Journal of Cardiovascular Development and Disease 10, no. 9: 386. https://doi.org/10.3390/jcdd10090386

Zhou, Y., Yuan, Z., Wang, M., Zhang, Z., Tan, C., Yu, J., Bi, Y., Liao, X., Zhou, X., Ali Sheikh, M. S., & Yang, D. (2023). Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice. Journal of Cardiovascular Development and Disease, 10(9), 386. https://doi.org/10.3390/jcdd10090386